Bertolino Arthur Peter
EVP and Chief Medical Officer at Revance Therapeutics, Inc.
- Sold, on record
- $303k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Nov 17, 2015
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Revance Therapeutics, Inc.EVP and Chief Medical Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Revance Therapeutics, Inc.Plan not statedNov 17 2015
Sold 7,753 shares at $39.11 ($303k)
Bertolino Arthur Peter, EVP and Chief Medical Officer
Sold 18.6% of holdings ($1.6M position)34,001 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (1)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2015 | Revance Therapeutics, Inc. | EVP and Chief Medical Officer | Form 4 sale | 7,753 | $303k | 18.6% | Plan not stated | SEC |